These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 22195302)

  • 1. Prevention of diabetes and cardiovascular disease among prediabetic individuals: lifestyle versus drug interventions.
    Hu FB
    Eur J Cardiovasc Prev Rehabil; 2011 Dec; 18(6):810-2. PubMed ID: 22195302
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevention of diabetes and reduction in major cardiovascular events in studies of subjects with prediabetes: meta-analysis of randomised controlled clinical trials.
    Hopper I; Billah B; Skiba M; Krum H
    Eur J Cardiovasc Prev Rehabil; 2011 Dec; 18(6):813-23. PubMed ID: 21878448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes prevention programs.
    Ramachandran A; Snehalatha C
    Med Clin North Am; 2011 Mar; 95(2):353-72, viii. PubMed ID: 21281838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [For diabetes: prevention with diet or drugs].
    Henzen C
    Rev Med Suisse; 2012 Jan; 8(325):233-4. PubMed ID: 22338531
    [No Abstract]   [Full Text] [Related]  

  • 5. Prediabetes: Why Should We Care?
    Zand A; Ibrahim K; Patham B
    Methodist Debakey Cardiovasc J; 2018; 14(4):289-297. PubMed ID: 30788015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Joint ESC/EASD guidelines on diabetes, where are we now and where should we go?
    Rydén L; Mellbin L
    Curr Vasc Pharmacol; 2012 Nov; 10(6):690-2. PubMed ID: 23259555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AACE comprehensive diabetes management algorithm 2013.
    Garber AJ; Abrahamson MJ; Barzilay JI; Blonde L; Bloomgarden ZT; Bush MA; Dagogo-Jack S; Davidson MB; Einhorn D; Garvey WT; Grunberger G; Handelsman Y; Hirsch IB; Jellinger PS; McGill JB; Mechanick JI; Rosenblit PD; Umpierrez G; Davidson MH;
    Endocr Pract; 2013; 19(2):327-36. PubMed ID: 23598536
    [No Abstract]   [Full Text] [Related]  

  • 8. Prediabetes and macrovascular disease: Review of the association, influence on outcome and effect of treatment.
    Kleinherenbrink W; Osei E; den Hertog HM; Zandbergen AAM
    Eur J Intern Med; 2018 Sep; 55():6-11. PubMed ID: 30007840
    [No Abstract]   [Full Text] [Related]  

  • 9. [Trial of pioglitazone for the secondary prevention of cardiovascular events in patients with diabetes mellitus type 2: insufficient evidence].
    Veneman TF
    Ned Tijdschr Geneeskd; 2006 Apr; 150(16):931-2; author reply 932-3. PubMed ID: 16686096
    [No Abstract]   [Full Text] [Related]  

  • 10. [Trial of pioglitazone for the secondary prevention of cardiovascular events in patients with diabetes mellitus type 2: insufficient evidence].
    Heine RJ
    Ned Tijdschr Geneeskd; 2006 Apr; 150(16):930-1; author reply 932-3. PubMed ID: 16686095
    [No Abstract]   [Full Text] [Related]  

  • 11. Early, aggressive treatment is effective in treating diabetes. Risk of long-term complications reduced significantly.
    Duke Med Health News; 2012 Sep; 18(9):7. PubMed ID: 23029693
    [No Abstract]   [Full Text] [Related]  

  • 12. Review of an article: aspirin for primary prevention of cardiovascular events in people with diabetes. A position statement of the American Diabetes Association (ADA), a scientific statement of the American Heart Association(AHA), and an expert consensus document of the American College of Cardiology Foundation (ACCF). Diabetes Care, 33:6; June 2010; 1395-1402.
    Gilpin VL; ; ;
    J Vasc Nurs; 2010 Dec; 28(4):154-5. PubMed ID: 21074118
    [No Abstract]   [Full Text] [Related]  

  • 13. [ESC guidelines on diabetes, pre-diabetes and diseases of the cardiovascular system developed in cooperation with the EASD].
    ; Rydén L; Grant PJ; Anker SD; Berne C; Cosentino F; Danchin N; Deaton C; Escaned J; Hammes HP; Huikuri H; Marre M; Marx N; Mellbin L; Ostergren J; Patrono C; Seferovic P; Sousa Uva M; Taskinen MR; Tendera M; Tuomilehto J; Valensi P; Zamorano JL;
    Kardiol Pol; 2013; 71 Suppl 11():S319-94. PubMed ID: 24297732
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prediabetes: diagnosis, evaluation of chronic complications, and treatment].
    Souza CF; Gross JL; Gerchman F; Leitão CB
    Arq Bras Endocrinol Metabol; 2012 Jul; 56(5):275-84. PubMed ID: 22911279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lifestyle and medication interventions for the prevention or delay of type 2 diabetes mellitus in prediabetes: a systematic review of randomised controlled trials.
    Yuen A; Sugeng Y; Weiland TJ; Jelinek GA
    Aust N Z J Public Health; 2010 Apr; 34(2):172-8. PubMed ID: 23331362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Primary prevention of diabetes mellitus type 2].
    Gallwitz B
    Internist (Berl); 2004 Jun; 45 Suppl 1():S15-22. PubMed ID: 15241504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anti-diabetic therapy and cardiovascular disease].
    Mannucci E
    G Ital Cardiol (Rome); 2016 Mar; 17(3 Suppl 2):3s-4. PubMed ID: 27030117
    [No Abstract]   [Full Text] [Related]  

  • 18. DREAM study and its impact on India.
    Mohan V
    J Assoc Physicians India; 2006 Oct; 54():765-7. PubMed ID: 17214271
    [No Abstract]   [Full Text] [Related]  

  • 19. [Prediabetes: problem of prevention].
    Liberti R
    Policlinico Prat; 1968 Aug; 75(35):1125-39. PubMed ID: 5704528
    [No Abstract]   [Full Text] [Related]  

  • 20. Multifactorial lifestyle interventions in the primary and secondary prevention of cardiovascular disease and type 2 diabetes mellitus--a systematic review of randomized controlled trials.
    Angermayr L; Melchart D; Linde K
    Ann Behav Med; 2010 Aug; 40(1):49-64. PubMed ID: 20652464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.